RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) Stock Analyst Earnings Estimates
TSX-V:RHT - TSX Venture Exchange - CA75955T1030 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.143M 528.35% | 1.462M 27.92% | 8.552M 484.87% | 17.661M 106.52% | 35.221M 99.43% | 99.879M 183.58% | |
| EBITDA YoY % growth | -10.721M 15.67% | -11.501M -7.28% | -8.18M 28.87% | 447.947K 105.48% | 6.135M 1,269.58% | 32.209M 425.00% | |
| EBIT YoY % growth | -11.166M 16.34% | -11.627M -4.13% | -8.296M 28.65% | -3.09K 99.96% | 5.99M 193,951.13% | 32.069M 435.38% | |
| Operating Margin | -976.87% | -795.19% | -97.01% | -0.02% | 17.01% | 32.11% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.01 | 0.03 200.00% | 0.12 300.00% |
All data in CAD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 200.00% | 0.03 50.00% |
| Revenue Q2Q % growth | 4.959M 116.69% | 5.011M 44.32% | 5.857M 42.21% | 7.468M 57.52% | 16.887M 240.53% | 20.231M 303.73% | 24.328M 315.37% | 25.68M 243.87% | 29.64M 75.52% |
| EBITDA Q2Q % growth | 413.03K 134.74% | 437.75K 162.53% | 552.08K 991.71% | 1.191M 74.89% | 3.954M 857.32% | 6.048M 1,281.61% | 8.011M 1,351.06% | 8.434M 608.14% | 9.716M 145.73% |
| EBIT Q2Q % growth | 375.95K 128.82% | 401.7K 155.19% | 515K 7,740.95% | 1.155M 94.02% | 3.918M 942.16% | 6.013M 1,396.89% | 7.976M 1,448.74% | 8.399M 627.19% | 9.681M 147.09% |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 4.741M 88.51% | % | ||
| Q2 2023 Q2Q % growth | 4.119M 92.44% | % | ||
| Q1 2023 Q2Q % growth | 3.472M 115.91% | % | ||
| Q4 2022 Q2Q % growth | 2.289M 470.04% | % | ||
| Q3 2022 Q2Q % growth | 2.515M 469.02% | % | ||
| Q2 2022 Q2Q % growth | 2.14M 263.85% | % | ||
| Q1 2022 Q2Q % growth | 1.608M 700.48% | % | ||
| Q4 2021 Q2Q % growth | 401.46K 3,310.88% | % | ||
| Q3 2021 Q2Q % growth | 441.99K -3.30% | % | ||
| Q2 2021 Q2Q % growth | 588.18K 46.74% | % | ||
| Q1 2021 Q2Q % growth | 200.9K -26.51% | % | ||
| Q4 2020 Q2Q % growth | 11.77K -80.87% | % | ||
| Q3 2020 Q2Q % growth | 457.08K 359.24% | % | ||
| Q2 2020 Q2Q % growth | 400.82K 1,822.40% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |